Trial NCT05564416

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2022-08062
Secondary IDs: 10517 NCI-2022-08062 UM1CA186644

Last trial update was posted on 2024-03-05

MeSH Interventions

Antibodies, Monoclonal Atezolizumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Bladder Carcinoma Bladder Urothelial Carcinoma Muscle Invasive Bladder Carcinoma Renal Pelvis and Ureter Urothelial Carcinoma Stage II Bladder Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 Stage IVA Bladder Cancer AJCC v8 Urothelial Carcinoma

Stopping Reasons

Feasibility issues per Complete Sheet

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID